P2Y₁₂ Inhibitors in Patients With Chronic Kidney Disease: The Known Unknown

JACC Cardiovasc Interv. 2017 Oct 23;10(20):2026-2028. doi: 10.1016/j.jcin.2017.06.028. Epub 2017 Aug 2.

Author

Hitinder S Gurm¹

Affiliation

¹ Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan; Department of Medicine, Veterans Affairs Medical Center, Ann Arbor, Michigan. Electronic address: hgurm@med.umich.edu.

PMID: 28780024
DOI: 10.1016/j.jcin.2017.06.028

No abstract available

Keywords: chronic kidney disease; prasugrel; ticagrelor.

Publication types

Editorial
Comment

MeSH terms

Acute Coronary Syndrome
Clopidogrel*
Humans
Percutaneous Coronary Intervention
Prasugrel Hydrochloride*
Purinergic P2Y Receptor Antagonists
Renal Insufficiency, Chronic

Substances

Purinergic P2Y Receptor Antagonists
Clopidogrel
Prasugrel Hydrochloride